ARTES Biotechnology and Bio Farma have collaborated to develop and manufacture vaccine candidates.
As part of the mutually agreed collaboration, both companies have already signed a first agreement for virus-like particles (VLP) based vaccine technology transfer in Bandung, Indonesia.
Go deeper with GlobalData
ARTES’s Metavax patent protected VLP technology has been designed to develop and produce safe and cost-effective vaccines, claimed the company.
When compared to other existing VLP approaches in the market, Metavax platform provides a highly potent immune response and enhanced protection as it is based on modifications to duck hepatitis B virus.
ARTES Biotechnology founder and managing director Dr Michael Piontek said Bio Farma is a reliable pharmaceutical partner and the only vaccine and antisera producer for humans in Indonesia.
See Also:
"We are more than confident, that we along with Bio Farma will develop vaccines highly relevant for the Indonesian and neighboring markets," Piontek said.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData"We expect that especially developments based on our Metavax technology will contribute to Bio Farma’s vaccine portfolio."
The commitment is fully supported by the Indonesian Government, including assistance in the area of policy-making to help speed up the process of developing vaccines in the country.
ARTES specialises in cell line and process development, VLP based vaccines in addition to in-technology transfer for pharmaceutically relevant production processes.
Bio Farma is involved in the manufacturing of vaccines, serum and other biological products for the Indonesian domestic and international markets.
Image: Bio Farma is only vaccine and antisera producer for humans in Indonesia. Photo: courtesy of Guzoer.
